When 'Price Gouging' Is Good: Michael Munger
The Duke economist and political scientist discusses the response to COVID-19, the coming recession, and the end of higher ed as we know it.
The Duke economist and political scientist discusses the response to COVID-19, the coming recession, and the end of higher ed as we know it.
The agency has hampered widespread COVID-19 testing and the production of both protective gear and hand sanitizer.
Before this, the wait period was a year.
Rules designed to keep alcohol safe for children are slowing down production of a product that’s in short supply.
The renowned science writer talks about pandemics, Chinese authoritarianism, Brexit, and why the freedom to innovate must not be quashed.
The Kentucky congressman who insisted Congress record its vote on history's biggest spending bill is unapologetic and outspoken about limited government.
Markets are trying to meet spiking demand for face masks, but importers are stymied by the FDA and CDC
The Kentucky Republican took on Donald Trump and Nancy Pelosi to fight against the $2 trillion coronavirus spending package. He's just getting started.
DIY manufacturers scramble to reduce shortages, as public health officials send mixed messages about the efficacy of broader use.
They were mocked for sounding the alarm. Now they're the ones providing the solutions.
The agency should relax the yearlong deferral period.
The agency concludes that the possible benefits outweigh the risks.
Reason's Ronald Bailey on flattening the curve without killing freedom.
Here is the best way to make sense of constantly changing predictions, says Reason Science Correspondent Ronald Bailey
An idea that could really speed up vaccine development
The agency's emphasis on caution over speed led to needless suffering and loss of life long before the COVID-19 pandemic.
A Q&A with Alex Tabarrok, an economist at George Mason University and blogger at Marginal Revolution
The companies are complying. Customers won't get their results and are being told to destroy their test kits.
Politicians are merely using COVID-19 to push for policies they already wanted.
But he stands by his reasoning and predicts that global deaths will peak under 50,000.
Established makers of N95 masks are ramping up production as fast as they can. New manufacturers hoping to help meet demand are running into regulatory roadblocks.
Restrictions have been loosened to help ramp up production.
No time to waste; do it sooner rather than later.
Private-sector efforts to fill the testing vacuum run afoul of bureaucracy.
If you really want politicians to do something helpful, ask them to stop "leading" and to get out of the way.
FDA is reportedly cutting red tape to give expanded access to COVID-19 patients.
How broken bureaucracy and poor political leadership combined to botch the rollout of COVID-19 testing
In the pandemic's wake, we'll learn, work, and live more online than ever.
Plus: Trump wants to bail out airlines, and he called COVID-19 the "Chinese virus."
From relaxed TSA rules to speedy FDA approvals, the coronavirus is forcing authorities to admit many of their regulations are unnecessary.
Despite the slow-growing anxieties and government incompetence, expect Americans to be resilient in fighting the pandemic.
The biotech entrepreneur and Silicon Valley visionary wants mandatory quarantines and a "digital Dunkirk" rescue operation.
The biotech entrepreneur and Silicon Valley visionary calls for a "digital Dunkirk" to fix government failure and preserve future freedoms.
FDA and CDC bureaucrats stopped private and academic diagnostic tests from being deployed.
The label changes include new font along with pointless and misleading information.
For now, the FDA is targeting the vaping products that are most popular with teenagers. But the industry still faces a potentially devastating regulatory deadline.
In response to intense opposition from vapers and the industry, the Trump administration has recalibrated its plan.
E-cigarettes are under attack, but they are a safer way to consume nicotine than conventional smoking, says Jacob Sullum.
Targeting CBD companies that make spurious health claims is one thing. Going after culinary experimentation is ridiculous.
In the panic to ban and regulate electronic cigarettes, media and politicians are ignoring the benefits of vaping.
The court was correct to reject most of the arguments, but was too dismissive of the First Amendment concerns.
A new review essay in Science warns of the dangers of prohibitionist thinking
Even if the FDA does not ban flavors, its regulations will soon drive most vaping businesses and products from the market.
CTPharma's collaboration with Yale researchers seems to be the first clinical trial involving U.S.-grown marijuana that is not supplied by the federal government.
Raw butterists are understandably salty about a prohibition on interstate commerce.
The distinction the presidential adviser draws between e-cigarettes and other vaping devices contradicts the FDA's understanding of its authority.
Plus: Buttigieg just behind Warren in Iowa, sex work in Scotland, anger in Russia, Trump impeachment news, a call for regulatory reform, and more...
Do you care about free minds and free markets? Sign up to get the biggest stories from Reason in your inbox every afternoon.
This modal will close in 10